GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Accounts Payable

Taisho Pharmaceutical Holdings Co (TSE:4581) Accounts Payable : 円16,503 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Accounts Payable?

Taisho Pharmaceutical Holdings Co's Accounts Payable for the quarter that ended in Dec. 2023 was 円16,503 Mil.

Taisho Pharmaceutical Holdings Co's quarterly Accounts Payable declined from Jun. 2023 (円16,730 Mil) to Sep. 2023 (円16,250 Mil) but then increased from Sep. 2023 (円16,250 Mil) to Dec. 2023 (円16,503 Mil).

Taisho Pharmaceutical Holdings Co's annual Accounts Payable increased from Mar. 2021 (円14,672 Mil) to Mar. 2022 (円15,101 Mil) and increased from Mar. 2022 (円15,101 Mil) to Mar. 2023 (円17,001 Mil).

Taisho Pharmaceutical Holdings Co Accounts Payable Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Accounts Payable Chart

Taisho Pharmaceutical Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,814.00 18,045.00 14,672.00 15,101.00 17,001.00

Taisho Pharmaceutical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,535.00 17,001.00 16,730.00 16,250.00 16,503.00

Taisho Pharmaceutical Holdings Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Taisho Pharmaceutical Holdings Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Accounts Payable
Comparable Companies
TSE:4530 TSE:4516 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4553 TSE:4521 TSE:4534 TSE:4551 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
TAIPY:USA TAISF:USA
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Website
http://www.taisho-holdings.co.jp
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines